A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: A nationwide study of 11,950 patients

Annals of Surgery

Volumn 261, Issue 3, 2015, Pages 513-520

  Utsunomiya, Tohru ^a   Shimada, Mitsuo ^a   Kudo, Masatoshi ^b   Ichida, Takafumi ^c   Matsui, Osamu ^d   Izumi, Namiki ^e   Matsuyama, Yutaka ^f   Sakamoto, Michiie ^g   Nakashima, Osamu ^h   Ku, Yonson ⁱ   Takayama, Tadatoshi ^j   Kokudo, Norihiro ^k  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e MUSASHINO RED CROSS HOSPITAL   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KEIO UNIVERSITY   (Japan)

^h KURUME UNIVERSITY HOSPITAL   (Japan)

ⁱ KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j NIHON UNIVERSITY   (Japan)

^k UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Hepatic resection; Nationwide study; Non B non C hepatocellular carcinoma; Prognosis

Indexed keywords

INDOCYANINE GREEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TREATMENT OUTCOME; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS E VIRUS; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS E VIRUS; HUMANS; INCIDENCE; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84927044829     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000821     Document Type: Article

References (39)

1. Ikai I, Arii S, OkazakiM, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37: 676-691.
2. Namiki I, Nishiguchi S, Hino K, et al. Management of hepatitis C: Report of the consensus meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res. 2010;40: 347-368.
3. Nishikawa H, Osaki Y. Non-B non-C hepatocellular carcinoma (review). Int J Oncol. 2013;43: 1333-1342.
4. Tanaka H, Imai Y, Hiramatsu N, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148: 820-826.
5. Utsunomiya T, Shimada M. Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma. Hepatol Res. 2011;41: 711-721.
6. Takenaka K, Yamamoto K, Taketomi A, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology. 1995;22: 20-24.
7. Sasaki Y, Yamada T, Tanaka H, et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B-or hepatitis C-related hepatocellular carcinoma. Ann Surg. 2006;244: 771-780.
8. Kao WY, Su CW, Chau GY, et al. A comparison of prognosis between patientswith hepatitisBand Cvirus-related hepatocellular carcinoma undergoing resection surgery. World J Surg. 2011;35: 858-867.
9. Honda M, Yamashita T, Ueda T, et al. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology. 2006;44: 1122-1138.
10. Pawlik TM, Poon RT, Abdalla EK, et al. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg. 2004;8: 794-804.
11. Li Q, Li H, Qin Y, et al. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A Chinese experience. J Gastroenterol Hepatol. 2007;22: 1936-1941.
12. Tanaka K, Shimada H, Matsuo K, et al. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Ann Surg Oncol. 2007;14: 1170-1181.
13. Nanashima A, Abo T, Sumida Y, et al. Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: Relationship with status of viral hepatitis. J Surg Oncol. 2007;96: 487-492.
14. Kondo K, Chijiiwa K, Funagayama M, et al. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg. 2008;12: 468-476.
15. Cescon M, Cucchetti A, Grazi GL, et al. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A Western dual-center experience. Arch Surg. 2009;144: 906-913.
16. Zhou Y, Si X, Wu L, et al. Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: A metaanalysis of observational studies. World J Surg Oncol. 2011;9: 108.
17. Kaneda K, Kubo S, Tanaka H, et al. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma. Hepatogastroenterology. 2012;59: 1889-1892.
18. Kaibori M, Ishizaki M, Matsui K, et al. Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy. Am J Surg. 2012;204: 300-307.
19. Nishikawa H, Arimoto A, Wakasa T, et al. Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. J Cancer. 2013;4: 502-513.
20. Li T, Qin LX, Gong X, et al. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 2013;119: 126-135.
21. Kudo A, Tanaka S, Ban D, et al. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: A propensity score analysis. J Gastroenterol. 2014;49: 1352-1361.
22. Welzel TM, Graubard BI, Zeuzem S, et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-Medicare database. Hepatology. 2011;54: 463-471.
23. Utsunomiya T, Shimada M, Kudo M, et al. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg. 2014;259: 336-345.
24. Makuuchi M, Kokudo N, Arii S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res. 2008;38: 37-51.
25. The Liver Cancer Study Group of Japan. TheGeneral Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd English ed. Tokyo, Japan: Kanehara & Co, Ltd; 2003.
26. Schneider HJ, Wallaschofski H, Völzke H, et al. Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction. PLoS One. 2012;7: E33084.
27. Schlaeger C, Longerich T, Schiller C, et al. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology. 2008;47: 511-520.
28. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142: 1264-1273.
29. Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBVand HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13: 123-135.
30. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology. 1995;22: 1027-1033.
31. Yang WJ, Chang CJ, Yeh SH, et al. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways. Hepatology. 2009;49: 1515-1524.
32. Tokushige K, Hashimoto E, Horie Y, et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: Report of the nationwide survey. J Gastroenterol. 2011;46: 1230-1237.
33. Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis. Hepatology. 2009;49: 851-859.
34. Shrager B, Jibara G, Schwartz M, et al. Resection of hepatocellular carcinoma without cirrhosis. Ann Surg. 2012;255: 1135-1143.
35. Abe H, Yoshizawa K, Kitahara T, et al. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol. 2008;43: 967-974.
36. Takuma Y, Nouso K, Makino Y, et al. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol. 2011; 26: 1417-1424.
37. Utsunomiya T, Shimada M, Imura S, et al. Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol. 2010;45: 146-152.
38. Huang ZY, Liang BY, Xiong M, et al. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: A single-center experience in China. Ann Surg Oncol. 2012;19: 2515-2525.
39. Wang B, Xia CY, Lau WY, et al. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: A new strategy for hepatic surgery. J Am Coll Surg. 2013;217: 1054-1062.